What a 2026 Lancet Psychiatry Review Actually Shows, and What It Doesn’t
Comments Off on What a 2026 Lancet Psychiatry Review Actually Shows, and What It Doesn’t
April 27, 2026
This cannabinoids mental health meta-analysis reviews 54 randomized trials across psychiatric and substance use conditions. It identifies modest benefits in insomnia, Tourette syndrome, ASD traits, and cannabis withdrawal, but with low certainty. For…
Taylor et al – 2017 – Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy light
Comments Off on Taylor et al – 2017 – Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy light
April 1, 2026
Taylor et al - 2017 - Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy light
Cannabis and sleep, what patients get wrong and what clinicians should explain #2
Comments Off on Cannabis and sleep, what patients get wrong and what clinicians should explain #2
March 18, 2026
A concept focused on common misunderstandings in sleep care and evidence-based cannabinoid framing.
D.C. Tightens Cannabis Ads and Virginia Moves Toward Adult-Use Sales
Comments Off on D.C. Tightens Cannabis Ads and Virginia Moves Toward Adult-Use Sales
February 23, 2026
The DMV cannabis landscape is evolving fast: D.C.: Tightening ads — limiting youth exposure, content rules Virginia: Building retail framework — July applications, Nov sales One jurisdiction refining. One building from scratch. Both navigating the same…